Showing results 1 to 5 of 5
| Title | Author(s) | Issue Date | |
|---|---|---|---|
Antibody effector function and T cell reponses to homologous and heterologous inactivated or mRNA vaccines against SARS-CoV-2 Proceeding/Conference:Correlates of Protection for Next Generation Influenza Vaccines: Lessons learned from the COVID pandemic (01/03/2023-03/03/2023, Seattle) | 3-Mar-2023 | ||
Identifying mediators of protection for CoronaVac, an inactivated SARS-CoV-2 vaccine Proceeding/Conference:Individual and population immunity to respiratory viruses (Immunity 2023) (08/11/2023-10/11/2023) | 10-Nov-2023 | ||
Immunogenicity and durability of immune responses to mRNA and inactivated COVID-19 vaccines among healthcare workers in Hong Kong Proceeding/Conference:Options XI (26/09/2022-29/09/2022, Belfast, UK) | 29-Sep-2022 | ||
Serologic correlates of protection against infection of COVID-19 vaccines: preliminary findings from a randomised trial of homologous and heterologous inactivated and mRNA third-dose vaccination (the Cobovax study) Proceeding/Conference:Correlates of Protection for Next Generation Influenza Vaccines: Lessons learned from the COVID pandemic (01/03/2023-03/03/2023, Seattle) | 3-Mar-2023 | ||
Seroprevalence of COVID-19 in healthcare workers Proceeding/Conference:Options XI (26/09/2022-29/09/2022, Belfast, UK) | 29-Sep-2022 |